Major Vault Protein (MVP) Associated With BRAF V600E Mutation Is an Immune Microenvironment-Related Biomarker Promoting the Progression of Papillary Thyroid Cancer via MAPK/ERK and PI3K/AKT Pathways.
GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours.
Endocrine-Related Cancer
Paulsson, Johan O JO; Wang, Na N; Gao, Jiwei J; Stenman, Adam A; Zedenius, Jan J; Mu, Ninni N; Lui, Weng-Onn WO; Larsson, Catharina C; Juhlin, C Christofer CC
Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model.
Oncotarget
Danysh, Brian P BP; Rieger, Erin Y EY; Sinha, Deepankar K DK; Evers, Caitlin V CV; Cote, Gilbert J GJ; Cabanillas, Maria E ME; Hofmann, Marie-Claude MC